Garsorasib (Synonyms: D-1553) |
| Catalog No.GC64723 |
가르소라십은 IC50이 10nM인 KRAS G12C의 강력한 억제제입니다. 가르소라십은 췌장암, 자궁내막암, 결장직장암, 폐암(비소세포폐암) 등 다양한 암에 대한 연구 잠재력이 있다(특허 WO2020233592A1, 화합물 2에서 발췌).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2559761-14-5
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Garsorasib is a potent inhibitor of KRAS G12C with an IC50 of 10 nM. Garsorasib has the potential for the research of various cancer such as pancreatic cancer, endometrial cancer, colorectal cancer, or lung cancer (non-small cell lung cancer) (extracted from patent WO2020233592A1, compound 2)[1].
[1]. Wang, Lisha, et al. Cbp/ep300 inhibitor and use thereof. Patent WO2021213521A1.
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *